Basis for the selective antibacterial activity in vitro of proton pump inhibitors against Helicobacter spp
- PMID: 9257764
- PMCID: PMC164008
- DOI: 10.1128/AAC.41.8.1797
Basis for the selective antibacterial activity in vitro of proton pump inhibitors against Helicobacter spp
Abstract
Proton pump inhibitors of the benzimidazole type exert a specific antibacterial activity against Helicobacter pylori in vitro. In the present study, the basis for this selectivity was investigated, and in particular, various factors affecting the in vitro antibacterial activity of sulfide analogs of benzimidazoles were studied. Upon preincubation of omeprazole for a period of up to 72 h in a buffer at pH 7, a product was formed that was bactericidal for H. pylori but had no effect on urease activity. Sulfide constitutes the main end product of degradation. The sulfide analog of omeprazole (H 168/22) exerted a bactericidal activity specifically against both resting (in buffer) and growing (in broth) Helicobacter spp., and time-kill in buffer at pH 5 was enhanced compared to that at pH 7. There was no or very low covalent binding of 3H-labeled H 168/22 to Helicobacter spp. or to other gram-negative and gram-positive bacteria. In the presence of fetal calf serum (FCS) under the same conditions, binding was only slightly lowered while the killing activity was markedly reduced, indicating a probably nonspecific interaction with proteins and/or protection of bacterial target(s) by FCS. Addition of H 168/22 (four times the minimum bactericidal concentration [MBC]) to exponentially growing H. pylori immediately stopped growth, and after an incubation period of 20 h viable counts were reduced by >7 log10. One-hour exposure of H. pylori to the drug followed by repeated washing retarded growth by about 2 h, indicating that the effect is reversible after short-term exposure. MICs and MBCs of various sulfide structures were lower than those obtained in broth after the addition of the corresponding sulfoxide. Thus, the MBC of the sulfide structure of omeprazole against 140 clinical isolates of H. pylori ranged from 8 to 32 microg/ml, compared to an MBC of omeprazole of 32 to 128 microg/ml. A similar potency was also recorded against other helicobacters. In conclusion, formation of sulfides of benzimidazoles in culture media is the reason for the selective antibacterial effect against H. pylori. The sulfides rapidly exerted a reversible antibacterial activity, which was specific against both resting and growing Helicobacter spp. without any covalent protein binding.
Similar articles
-
In vitro antibacterial activity of omeprazole and its selectivity for Helicobacter spp. are dependent on incubation conditions.Antimicrob Agents Chemother. 1996 Mar;40(3):621-6. doi: 10.1128/AAC.40.3.621. Antimicrob Agents Chemother. 1996. PMID: 8851582 Free PMC article.
-
A proton pump inhibitor, E3810, has antibacterial activity through binding to Helicobacter pylori.J Gastroenterol. 1995 Aug;30(4):461-4. doi: 10.1007/BF02347561. J Gastroenterol. 1995. PMID: 7550855
-
Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori.Antimicrob Agents Chemother. 1991 Mar;35(3):490-6. doi: 10.1128/AAC.35.3.490. Antimicrob Agents Chemother. 1991. PMID: 2039199 Free PMC article.
-
Rabeprazole: the role of proton pump inhibitors in Helicobacter pylori eradication.Expert Rev Anti Infect Ther. 2005 Dec;3(6):863-70. doi: 10.1586/14787210.3.6.863. Expert Rev Anti Infect Ther. 2005. PMID: 16307499 Review.
-
Helicobacter pylori infection, chronic gastritis, and proton pump inhibitors.J Clin Gastroenterol. 1998;27 Suppl 1:S163-9. doi: 10.1097/00004836-199800001-00027. J Clin Gastroenterol. 1998. PMID: 9872516 Review.
Cited by
-
Antiinfectives targeting enzymes and the proton motive force.Proc Natl Acad Sci U S A. 2015 Dec 22;112(51):E7073-82. doi: 10.1073/pnas.1521988112. Epub 2015 Dec 7. Proc Natl Acad Sci U S A. 2015. PMID: 26644565 Free PMC article.
-
Proposal to Consider Chemical/Physical Microenvironment as a New Therapeutic Off-Target Approach.Pharmaceutics. 2022 Sep 29;14(10):2084. doi: 10.3390/pharmaceutics14102084. Pharmaceutics. 2022. PMID: 36297518 Free PMC article.
-
A Chemical Genetics Screen Reveals Influence of p38 Mitogen-Activated Protein Kinase and Autophagy on Phagosome Development and Intracellular Replication of Brucella neotomae in Macrophages.Infect Immun. 2019 Jul 23;87(8):e00044-19. doi: 10.1128/IAI.00044-19. Print 2019 Aug. Infect Immun. 2019. PMID: 31160361 Free PMC article.
-
The Possible Role of Helicobacter pylori in Gastric Cancer and Its Management.Front Oncol. 2019 Feb 22;9:75. doi: 10.3389/fonc.2019.00075. eCollection 2019. Front Oncol. 2019. PMID: 30854333 Free PMC article. Review.
-
Binding of omeprazole to protein targets identified by monoclonal antibodies.PLoS One. 2020 Sep 18;15(9):e0239464. doi: 10.1371/journal.pone.0239464. eCollection 2020. PLoS One. 2020. PMID: 32946534 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous